• Inicio
  • Formações
  • Formação à Medida
  • News & Trends
  • Sobre nós
  • Contacto

FDA Guidances on Device User Fees, MDUFA IV Goals & Pre-Submissions

The FDA has issued new  guidances for  medical device makers :

User Fee Guidances:

User Fees and Refunds for Premarket Notification Submissions (510(k)s)

User Fees and Refunds for Premarket Approval Applications and Device Biologics License Applications

User Fees and Refunds for De Novo Classification Requests

User Fees for 513(g) Requests for Information

Action Guidances:

FDA and Industry Actions on Premarket Notification (510(k)) Submissions: Effect on FDA Review Clock and Goals

FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Goals

FDA and Industry Actions on De Novo Classification Requests: Effect on FDA Review Clock and Goals

Pre-Submission Program:

Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff

News & Trends

Procurar

Recentes

  • ICH HARMONISED GUIDELINE GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R3) Annex 2 .Final version
  • Team-NB Position Paper: MDR Certification Process (including Pre-application, Application and Post Application phases) – Consensus document
  • 2025 AI Observatory report
  • The EU new standard template covering recruitment and informed consent procedures.
  • EXTENSION OF THE MDR TRANSITIONAL PERIOD AND REMOVAL OF THE ‘SELL OFF’ PERIODS – Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607
  • MEDTECH EUROPE : An Improved Regulatory Framework: What Do Europe’s Diagnostics Need?
  • European Data Protection Board public consultation on the draft Guidelines on the processing of personal data for scientific research
  • Statistical Approaches to Establishing Bioequivalence

91 257 00 03 (Chamada para a rede móvel nacional)
info@formiventos.com

  • Follow
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto